Get Live Data

We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Ekf Diagnostics Share Price
  4. Ekf Diagnostics Share Regulatory News
  5. Appointment of a Director

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Ekf Diagnostics Information

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.70
Bid: 27.20
Ask: 28.90
Change: 0.45 (1.63%)
Spread: 1.70 (6.25%)
Open: 27.70
High: 27.70
Low: 27.70
Prev. Close: 27.60
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of a Director

21 Dec 2015 07:00

RNS Number : 6546J
EKF Diagnostics Holdings PLC
21 December 2015
 

 

21 December 2015

EKF Diagnostics Holdings plc("EKF" or the "Company")

 

Directorate Change

 

EKF Diagnostics Holdings plc (AIM: EKF) is pleased to announce that Lurene Joseph joins the Board as a non-executive director with immediate effect.

 

Lurene has held Chief Executive positions at Leeds and Partners Limited and the London Development Agency, a strategic organisation responsible for jobs, skills and economic growth in London. At both organisations, Lurene was instrumental in bringing about transformational change and driving value with a focus on delivery. Prior to joining the London Development Agency, Lurene was a member of the management team at Royal Dutch Shell Plc and a Vice President at TXU Energy Retail Company LLC.

 

Disclosures in accordance with the AIM Rules for Lurene Julia Wong Joseph, aged 55:

Current DirectorshipsMaraval Limited

Past Directorships in the previous five yearsLeeds and Partners LimitedLondon Development AgencyWomen’s Pioneer HousingRoyal Docks Management AuthoritySME Wholesale Finance Limited

Lurene was a director of Leeds and Partners Limited which was put into voluntary liquidation on 31 March 2015 as part of a strategic move to a wider regional inward investment agenda.

There are no further disclosures required in accordance with AIM Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies.

 

EKF Diagnostics Holdings plc

Tel: 029 2071 0570

Ron Zwanziger, Non-Executive Chairman

Tel: +1 339 221 6282

Julian Baines, CEO

Mob: 07788 420 859

 

 

Panmure Gordon (UK) Limited

Tel: 020 7886 2500

Robert Naylor (Corporate Finance)

Paul Fincham (Corporate Finance)

 

 

Walbrook PR Limited 

Tel: 020 7933 8780 or ekf@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABBLFLELFBFBQ
12345678910
Date   Source Headline
13th Jun 20227:00 amRNSUpdate on strong cash position
9th Jun 20227:00 amRNSLaunch of EKF Link
23rd May 20227:00 amRNSCancellation of Treasury Shares and TVR
18th May 20221:25 pmRNSResult of AGM
18th May 20227:00 amRNSAGM Statement
3rd May 20227:00 amRNSPDMR/Director Dealings & Holding(s) in Company
25th Apr 20227:00 amRNSPosting of Annual Report & Accounts &Notice of AGM
11th Apr 20227:00 amRNSPurchase of Own Shares & Buyback Prog. Completion
8th Apr 20227:00 amRNSPurchase of Own Shares
7th Apr 20227:00 amRNSPurchase of Own Shares
6th Apr 20227:00 amRNSPurchase of Own Shares
5th Apr 20227:00 amRNSPurchase of Own Shares
4th Apr 20227:00 amRNSPurchase of Own Shares
1st Apr 20227:00 amRNSPurchase of Own Shares
31st Mar 20227:00 amRNSPurchase of Own Shares
30th Mar 20227:00 amRNSPurchase of Own Shares
29th Mar 20227:01 amRNSShare Buyback Programme
29th Mar 20227:00 amRNSFinal Results
25th Mar 20224:40 pmRNSSecond Price Monitoring Extn
25th Mar 20224:35 pmRNSPrice Monitoring Extension
18th Mar 20225:13 pmRNSHolding(s) in Company
7th Mar 20227:00 amRNSFurther Investment in Verici Dx plc
3rd Mar 20224:41 pmRNSSecond Price Monitoring Extn
3rd Mar 20224:36 pmRNSPrice Monitoring Extension
3rd Mar 20227:00 amRNSNotice of Results
31st Jan 20227:00 amRNSNon-executive Directorate Change
25th Jan 20227:00 amRNSTrading update
18th Jan 20227:01 amRNSStrategic partnership agreement with Yourgene
23rd Nov 20217:00 amRNSDirectorate Change
8th Nov 20211:01 pmRNSDirector/PDMR Shareholding
25th Oct 20217:00 amRNSDividend confirmation
12th Oct 20217:00 amRNSCompletion of ADL Health Acquisition
5th Oct 20213:00 pmRNSPDMR/ PCA Dealings
5th Oct 20213:00 pmRNSHolding(s) in Company
28th Sep 20217:00 amRNSAcquisition of Advanced Diagnostic Laboratory LLC
14th Sep 20217:00 amRNSHalf-year Report
25th Aug 20217:00 amRNSNotice of Results
21st Jul 20217:00 amRNSTrading Update
16th Jun 20217:00 amRNSChange of Adviser
7th Jun 202110:10 amRNSInvestor Presentations
26th May 20215:48 pmRNSTrellus Health plc: Successful Restricted Offer
20th May 20214:31 pmRNSTrellus Health plc: Confirmation of Issue Price
19th May 202112:58 pmRNSResult of AGM
19th May 20217:01 amRNSBoard Changes and Executive Performance Bonus
19th May 20217:00 amRNSAGM Statement
18th May 20217:00 amRNSTrellus Health plc: Intention to Float - AIM
5th May 202111:14 amRNSNotice of Change of AGM Venue and Dividend Update
30th Apr 20213:52 pmRNSDirector/PDMR Shareholding
23rd Apr 20217:00 amRNSPosting of Annual Report &Accounts & Notice of AGM
22nd Apr 20217:00 amRNSDirector/PDMR Shareholding
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.